CEO Elon Musk appeared to confirm plans for a listing in December. The company could seek to raise $30 billion.

Aktis Oncology is aiming to bring in $182 million—or more—from what looks set to be the first biotech IPO of 2026. | Aktis ...

US initial public offerings delivered underwhelming results in 2025 as equity-market volatility and increasing scrutiny ...

BW Industrial Holdings Inc.’s IPO aims for a rich Price/Sales despite volatile, project-based revenue, sales drop and client ...

Baidu plans a Hong Kong IPO spin-off of AI chip unit Kunlunxin, boosting valuation as AI/Cloud growth accelerates. See why ...

From Wall Street to Silicon Valley, attention is building around a rare convergence of potential blockbuster listings ...

EquipmentShare's recently filed IPO shines a light on not only its own finances but how they compare to its competitors.

SpaceX is targeting a record-breaking $30B IPO in 2026, but lofty valuations and IPO hype could leave investors better off ...

The Alibaba-backed firm is set to price its 25.4 million shares at HK$165 each, the top end of its marketed range, sources ...

Asia’s equity capital markets are expected to have another blockbuster year in 2026, building on a surge that pushed the ...

Chinese AI and semiconductor stocks have rallied since the breakout of the China-made DeepSeek-R1 AI model in January 2025.

BCCL has fixed a price band of ₹21 to ₹23 per share. At the upper end of the band, the company is valued at over ₹10,700 ...